Reaction Details Report a problem with these data
Target
Prostate-specific antigen
Ligand
BDBM50298717
Substrate
n/a
Meas. Tech.
ChEMBL_588029 (CHEMBL1048364)
Ki
13.7±n/a nM
Citation
 LeBeau, AM; Banerjee, SR; Pomper, MG; Mease, RC; Denmeade, SR Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer. Bioorg Med Chem 17:4888-93 (2009) [PubMed]  Article 
Target
Name:
Prostate-specific antigen
Synonyms:
APS | Gamma-seminoprotein | KLK3 | KLK3_HUMAN | Kallikrein-3 | P-30 antigen | PSA | Prostate specific antigen | Prostate-specific antigen | Semenogelase | Seminin
Type:
PROTEIN
Mol. Mass.:
28747.53
Organism:
Homo sapiens (Human)
Description:
ChEMBL_959198
Residue:
261
Sequence:
MWVPVVFLTLSVTWIGAAPLILSRIVGGWECEKHSQPWQVLVASRGRAVCGGVLVHPQWVLTAAHCIRNKSVILLGRHSLFHPEDTGQVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAVKVMDLPTQEPALGTTCYASGWGSIEPEEFLTPKKLQCVDLHVISNDVCAQVHPQKVTKFMLCAGRWTGGKSTCSGDSGGPLVCNGVLQGITSWGSEPCALPERPSLYTKVVHYRKWIKDTIVANP
  
Inhibitor
Name:
BDBM50298717
Synonyms:
CHEMBL574845 | benzyl(2S,5S,8S,11S,14S)-8-(4-aminobutyl)-14-formyl-1-hydroxy-5-(hydroxymethyl)-16-methyl-11-(2-(methylthio)ethyl)-3,6,9,12-tetraoxo-4,7,10,13-tetraazaheptadecan-2-ylcarbamate
Type:
Small organic molecule
Emp. Form.:
C31H50N6O9S
Mol. Mass.:
682.829
SMILES:
CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)C=O |r|
Structure:
Search PDB for entries with ligand similarity: